SAN FRANCISCO, November 11, 2026 — Oura, the smart ring maker, announced a $625 million acquisition of Counsel Health, an AI-native primary care startup, marking a significant shift in the company’s strategy from hardware maker to integrated health services platform. This deal is expected to close before the end of the year, with Counsel Health’s CEO, Muthu Alagappan, joining Oura as chief clinical AI officer.
Background And History
Oura Health, founded in 2013, has established itself as a leader in the smart ring market, with over 5.5 million units sold as of June 2026, controlling roughly two-thirds of the US market. The company has partnered with various sports groups and organizations to monitor player health, and its ring has been recognized for its accuracy in tracking biometrics such as heart rate, respiration, and body temperature. Counsel Health, on the other hand, provides a chatbot that triages health concerns and escalates users to licensed physicians via telehealth, with a total funding of $36 million, including a $25 million Series A led by Andreessen Horowitz and GV.
Integration And Impact
The acquisition of Counsel Health will enable Oura to integrate biometric data with AI-driven primary care, offering users personalized medical advice and access to board-certified physicians within minutes. This integration is expected to change the competitive landscape for smart ring biometric data and preventative care, as Oura moves from being a hardware leader to a full-stack preventive care platform. With Counsel Health, Oura will be able to offer a more comprehensive health experience, combining passive biometric monitoring with AI-driven care. The deal also positions Oura as a vertically integrated health platform that can offer preventive, acute, chronic, and specialty care.
Market Dynamics And Competition
The acquisition puts Oura in direct competition with tech giants such as Apple, which has been adding health features to the Apple Watch, and Amazon, which is expanding its pharmacy and telehealth services. However, Oura’s approach is distinct, as it combines biometric data with AI-driven care, creating a seamless health experience. The deal also highlights the growing trend of consolidation in the healthcare AI market, with other companies such as Whoop and Function Health also moving into the health insights and clinical review space. Oura’s competitors, such as RingConn and Ultrahuman, are emerging to challenge its dominance in the smart ring market, but the acquisition of Counsel Health gives Oura a unique advantage in offering integrated health services.
Financials And Future Roadmap
Oura’s revenue jumped 153% to $533 million in the quarter preceding the deal, underscoring the company’s growth momentum. The acquisition is expected to close before the end of the year, with Counsel Health’s 70 employees, including CEO Muthu Alagappan, joining Oura. The deal represents a significant investment for Oura, which had postponed its planned IPO that could have valued the company at up to $2.2 billion. The acquisition price of $625 million is more than 17 times Counsel Health’s total funding, reflecting the strategic value of its clinical AI operation. As Oura looks to expand its business, the company is betting that combining passive biometric monitoring with AI-driven care can create a seamless health experience that neither pure hardware nor pure software companies can match. With a growing revenue and a strong balance sheet, Oura is well-positioned to integrate Counsel Health’s technology and expand its services to offer a more comprehensive health experience.
Sources
- Oura to acquire Counsel Health for $625 million, placing a big bet on AI care
- Oura Health
- Oura to acquire AI-native primary care startup Counsel Health for $625M | TechCrunch
- Oura Acquires AI Primary Care Startup for $625M After IPO Delay
- Oura to Acquire Counsel Health
- Oura buys AI primary care startup Counsel Health to put doctors in its app – Startup Fortune
Photo: Kyu3a (CC BY-SA 4.0)
